Skip to main content

Table 3 Hazard ratios of determinants associated with VKA discontinuation in NVAF

From: Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study

Factors

%

Crude HR

Adjusted HR (95 % CI)

Size, n

63,675

  

Age

18-29

0.07

1.60

1.65 (1.19 - 2.29)

30-39

0.19

1.47

1.48 (1.19 - 1.84)

40-49

0.89

1.00

1.00 (Reference)

50-59

3.59

0.88

0.88 (0.79 - 0.98)

60-69

16.79

0.83

0.83 (0.76 - 0.92)

70-74

19.82

0.82

0.82 (0.75 - 0.91)

75-79

23.78

0.78

0.79 (0.72 - 0.87)

80-84

19.80

0.74

0.75 (0.68 - 0.83)

85-89

11.10

0.77

0.79 (0.71 - 0.87)

≥90

3.97

0.77

0.80 (0.71 - 0.88)

Time to treatment initiation

0 day

39.51

1.00

1.00 (Reference)

1-7 days

23.73

1.07

1.11 (1.08 - 1.13)

8-30 days

12.11

1.00

1.04 (1.01 - 1.07)

31-90 days

5.99

1.02

1.04 (0.99 - 1.08)

>90 days

18.66

1.14

1.13 (1.10 - 1.17)

Male

48.46

1.08

1.03 (1.01 - 1.05)

Comorbidities

Hypertension

64.50

0.98

0.98 (0.96 - 1.01)

Myocardial infarction

19.73

1.13

1.08 (1.05 - 1.11)

Angina pectoris

19.79

1.10

1.06 (1.04 - 1.09)

Congestive heart failure

21.15

1.06

1.02 (0.99 - 1.05)

Prior stroke or TIA

9.36

0.90

0.90 (0.87 - 0.93)

Prior bleeding events

Intracranial bleeding

0.64

1.05

1.04 (0.92 - 1.18)

Gastrointestinal bleeding

4.44

1.13

1.06 (1.01 - 1.11)

Other bleeding

7.83

1.04

1.01 (0.97 - 1.04)

Diabetes

26.00

1.03

1.01 (0.99 - 1.04)

Hyperlipidemia

44.96

1.03

1.08 (1.03 - 1.13)

Vascular disease

11.52

1.10

1.06 (1.02 - 1.09)

Chronic renal failure

9.40

1.19

1.14 (1.10 - 1.18)

Complications of alcohol abuse

2.38

1.19

1.10 (1.03 - 1.17)

Liver disease

1.85

1.20

1.09 (1.02 - 1.17)

Cancer

16.72

1.14

1.13 (1.10 - 1.16)

Coagulation defects

1.42

1.16

1.08 (0.99 - 1.17)

Predisposition to falls

12.46

1.03

1.01 (0.98 - 1.04)

Dementia/schizophrenia

4.97

1.04

1.04 (0.99 - 1.09)

Venous thromboembolism

6.36

1.20

1.16 (1.12 - 1.21)

COPD

25.52

1.07

1.03 (1.01 - 1.06)

Medications

ACE

38.49

0.99

0.97 (0.95 - 1.00)

ARB

23.56

0.99

1.00 (0.97 - 1.02)

CCB

45.28

0.99

0.98 (0.96 - 1.01)

Diuretics

53.37

0.99

1.00 (0.98 - 1.02)

Antidepressants

17.18

1.03

1.02 (0.99 - 1.04)

Antipsychotics

3.64

1.07

1.03 (0.97 - 1.08)

NSAIDs

37.56

1.02

1.01 (0.99 - 1.03)

Statins

40.93

1.02

0.92 (0.88 - 0.97)

  1. Abbreviations: HR hazard ratio, TIA transient ischemic attack, COPD chronic obstructive pulmonary disease, ACE angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers, NSAIDs non-steroidal anti-inflammatory drugs